These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35746502)

  • 1. Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously with Hepatitis B Virus Vaccine, Group A Meningococcal Polysaccharide Vaccine, Measles-Rubella Combined Vaccine and Japanese Encephalitis Vaccine: A Multi-Center, Randomized, Controlled Clinical Trial in China.
    Liu X; Chang S; Wang R; Xiao Y; Li F; Xu Q; Zhang S; Chen X; Zhang S; Zhang M; Chen X; Cao Q; Liu X; Wang H; Zhan D; Chen H; Chen W; Jiang J; Zhang C; Wang H; Gao L; Shi X; Yang X; Xu A
    Vaccines (Basel); 2022 Jun; 10(6):. PubMed ID: 35746502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity and safety of an inactivated enterovirus 71 vaccine co-administered with measles-mumps-rubella vaccine and live-attenuated Japanese encephalitis vaccine: a phase 4, single-center, randomized controlled trial.
    Liu X; Yang W; Zhang C; Wu H; Wang R; Ding Q; Hu Y; Xiong Y; Zhang S; Wang L
    Hum Vaccin Immunother; 2021 Dec; 17(12):5348-5354. PubMed ID: 34905446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity and safety of the inactivated enterovirus 71 vaccine administered concomitantly with the measles-rubella vaccine in infants aged 8 months in China: A noninferiority randomized controlled trial.
    Zhao Z; Liao Y; Li Y; Jiang G; Huang Z; Yang H; Ou Z; Yin Q; Chen J; Deng Y; Jiang R; Che Y; Li Q; Zheng H; Zhang J
    Vaccine; 2022 Aug; 40(33):4709-4715. PubMed ID: 35753838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and Safety of an Inactivated Enterovirus 71 Vaccine Administered Simultaneously With Hepatitis B Vaccine and Group A Meningococcal Polysaccharide Vaccine: A Phase 4, Open-Label, Single-Center, Randomized, Noninferiority Trial.
    Zhang Z; Liang Z; Zeng J; Zhang J; He P; Su J; Zeng Y; Fan R; Zhao D; Ma W; Zeng G; Zhang Q; Zheng H
    J Infect Dis; 2019 Jul; 220(3):392-399. PubMed ID: 30891604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity and safety of measles-rubella vaccine co-administered with attenuated Japanese encephalitis SA 14-14-2 vaccine in infants aged 8 months in China: a non-inferiority randomised controlled trial.
    Li Y; Chu SY; Yue C; Wannemuehler K; Xie S; Zhang F; Wang Y; Zhang Y; Ma R; Li Y; Zuo Z; Rodewald L; Xiao Q; Feng Z; Wang H; An Z
    Lancet Infect Dis; 2019 Apr; 19(4):402-409. PubMed ID: 30833160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and safety of an enterovirus 71 vaccine in children aged 36-71 months: A double-blind, randomised, similar vaccine-controlled, non-inferiority phase III trial.
    Tong Y; Zhang X; Chen J; Chen W; Wang Z; Li Q; Duan K; Wei S; Yang B; Qian X; Li J; Hang L; Deng S; Li X; Guo C; Shen H; Liu Y; Deng P; Xie T; Li Q; Li L; Du H; Mao Q; Gao F; Lu W; Guan X; Huang J; Li X; Chen X
    EClinicalMedicine; 2022 Oct; 52():101596. PubMed ID: 35923425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and Immunogenicity of Enterovirus 71 Vaccine (Vero Cell) Administered Simultaneously with Trivalent Split-Virion Influenza Vaccine in Infants Aged 6-7 Months: A Phase 4, Randomized, Controlled Trial.
    Xiao Y; Guo X; Zhang M; Chen Y; Zhang Y; Yu X; Luo L; Chen H; Xu W; Liu H; Wu L; Hou R; Ma Y; Long L; Ruan J; Chen W; Yang X
    Vaccines (Basel); 2023 Apr; 11(4):. PubMed ID: 37112774
    [No Abstract]   [Full Text] [Related]  

  • 8. The immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine when co-administered with conjugated meningococcal C vaccine to healthy children: A phase IIIb, randomized, multi-center study in Italy.
    Durando P; Esposito S; Bona G; Cuccia M; Desole MG; Ferrera G; Gabutti G; Pellegrino A; Salvini F; Henry O; Povey M; Marchetti F
    Vaccine; 2016 Aug; 34(36):4278-84. PubMed ID: 27423382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interchangeability of two Enterovirus 71 inactivated vaccines in Chinese children: A phase IV, open-label, and randomized controlled trial.
    Xu Q; Cao Q; Yang W; Liu X; Liu H; Tian X; Li J; Fang X; Jia N; Zeng G; Xu A
    Vaccine; 2020 Mar; 38(12):2671-2677. PubMed ID: 32067817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and Safety of Inactivated Enterovirus 71 Vaccine in Children Aged 36-71 Months: A Double-Blind, Randomized, Controlled, Non-inferiority Phase III Trial.
    Zhang L; Gao F; Zeng G; Yang H; Zhu T; Yang S; Meng X; Mao Q; Liu X
    J Pediatric Infect Dis Soc; 2021 Apr; 10(4):440-447. PubMed ID: 33269798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China.
    Zhu F; Xu W; Xia J; Liang Z; Liu Y; Zhang X; Tan X; Wang L; Mao Q; Wu J; Hu Y; Ji T; Song L; Liang Q; Zhang B; Gao Q; Li J; Wang S; Hu Y; Gu S; Zhang J; Yao G; Gu J; Wang X; Zhou Y; Chen C; Zhang M; Cao M; Wang J; Wang H; Wang N
    N Engl J Med; 2014 Feb; 370(9):818-28. PubMed ID: 24571754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study.
    Wei M; Meng F; Wang S; Li J; Zhang Y; Mao Q; Hu Y; Liu P; Shi N; Tao H; Chu K; Wang Y; Liang Z; Li X; Zhu F
    J Infect Dis; 2017 Jan; 215(1):56-63. PubMed ID: 28077584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Phase I, randomized, open-label study to evaluate the safety and immunogenicity of an enterovirus 71 vaccine.
    Cheng A; Fung CP; Liu CC; Lin YT; Tsai HY; Chang SC; Chou AH; Chang JY; Jiang RH; Hsieh YC; Su IJ; Chong PC; Hsieh SM
    Vaccine; 2013 May; 31(20):2471-6. PubMed ID: 23541623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and safety of inactivated enterovirus A71 vaccines in children aged 6-35 months in China: a non-inferiority, randomised controlled trial.
    Li Y; Gao F; Wang Y; Li J; Zhang Y; Lv H; Wang S; Yang H; Liu X; Li K; Wang H; Yin Z; Liang Z; An Z; Mao Q; Feng Z
    Lancet Reg Health West Pac; 2021 Nov; 16():100284. PubMed ID: 34881371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of inactivated poliovirus vaccine when given with measles-rubella combined vaccine and yellow fever vaccine and when given via different administration routes: a phase 4, randomised, non-inferiority trial in The Gambia.
    Clarke E; Saidu Y; Adetifa JU; Adigweme I; Hydara MB; Bashorun AO; Moneke-Anyanwoke N; Umesi A; Roberts E; Cham PM; Okoye ME; Brown KE; Niedrig M; Chowdhury PR; Clemens R; Bandyopadhyay AS; Mueller J; Jeffries DJ; Kampmann B
    Lancet Glob Health; 2016 Aug; 4(8):e534-47. PubMed ID: 27364568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and safety of different sequential schedules of Sabin strain-based inactivated poliovirus vaccination: A randomized, controlled, open-label, phase IV clinical trial in China.
    Yan S; Chen H; Zhang Z; Chang S; Xiao Y; Luo L; Zhang Z; Sun L; Chen X; Yang Y; Shi X; Guo Y; Sun Y; Li H; Li N; Han S; Ma M; Yang X
    Vaccine; 2020 Sep; 38(40):6274-6279. PubMed ID: 32747216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An inactivated enterovirus 71 vaccine in healthy children.
    Li R; Liu L; Mo Z; Wang X; Xia J; Liang Z; Zhang Y; Li Y; Mao Q; Wang J; Jiang L; Dong C; Che Y; Huang T; Jiang Z; Xie Z; Wang L; Liao Y; Liang Y; Nong Y; Liu J; Zhao H; Na R; Guo L; Pu J; Yang E; Sun L; Cui P; Shi H; Wang J; Li Q
    N Engl J Med; 2014 Feb; 370(9):829-37. PubMed ID: 24571755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Zhu FC; Meng FY; Li JX; Li XL; Mao QY; Tao H; Zhang YT; Yao X; Chu K; Chen QH; Hu YM; Wu X; Liu P; Zhu LY; Gao F; Jin H; Chen YJ; Dong YY; Liang YC; Shi NM; Ge HM; Liu L; Chen SG; Ai X; Zhang ZY; Ji YG; Luo FJ; Chen XQ; Zhang Y; Zhu LW; Liang ZL; Shen XL
    Lancet; 2013 Jun; 381(9882):2024-32. PubMed ID: 23726161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness and Safety of an Inactivated Enterovirus 71 Vaccine in Children Aged 6-71 Months in a Phase IV Study.
    Guan X; Che Y; Wei S; Li S; Zhao Z; Tong Y; Wang L; Gong W; Zhang Y; Zhao Y; Wu Y; Wang S; Jiang R; Huang J; Liu Y; Luo W; Liao Y; Hu X; Zhang W; Dai Y; Jiang G; Min G; Liu F; You X; Xu X; Li J; Li C; Fan S; Hang L; Huang Q; Li Q
    Clin Infect Dis; 2020 Dec; 71(9):2421-2427. PubMed ID: 31734699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.